Lipid emulsions in clinical nutrition: Enteral and parenteral nutrition.

Q1 Agricultural and Biological Sciences
Edmundo Brito-de la Fuente, Sahylin Muñiz-Becerá, Gabriel Ascanio
{"title":"Lipid emulsions in clinical nutrition: Enteral and parenteral nutrition.","authors":"Edmundo Brito-de la Fuente,&nbsp;Sahylin Muñiz-Becerá,&nbsp;Gabriel Ascanio","doi":"10.1016/bs.afnr.2022.12.003","DOIUrl":null,"url":null,"abstract":"<p><p>Clinical nutrition emulsions are important products that can be life-saving for many patients suffering from gastrointestinal tract disorders, swallowing impairment, cancer, liver diseases, and many other clinical conditions. The transfer of lipids to the human body can be either intravenously (Parenteral Nutrition, PN) or through the gastrointestinal tract (Enteral Nutrition, EN). PN emulsions are considered pharmaceuticals and thus regulated accordingly. On the other hand, EN emulsions are classified as Food for Specific Medical Purposes (FSMP) and do not follow pharmaceutical regulations. Regarding product design, PN emulsions must follow theoretical emulsion formulation and production aspects, but special requirements regarding droplet size distribution must be followed to comply with national pharmacopeia monographs. Furthermore, a full clinical program on clinical evidence to prove safety and efficacy must be provided for marketing approval. On the contrary, EN emulsions require limited clinical evidence to substantiate health or clinical benefits. A short introduction to clinical nutrition with a focus on lipid emulsions is presented in this chapter. Furthermore, a general overview of the composition and main ingredients of clinical nutrition lipid emulsions is reviewed. Main clinical aspects are also mentioned here, highlighting the difficulties of clinically proving the efficacy of these products. The manufacturing and control of clinical nutrition emulsions are also reviewed, focusing on PN products and the main regulatory requirements related to the safety of these intravenous emulsions. Finally, stability and physicochemical properties are reviewed, and examples of commercially available products are used to illustrate these properties linked to the stability of these products. Lipids in clinical nutrition is a moving field and we do hope this chapter may remain a valuable source to understand newly emerging research on this topic.</p>","PeriodicalId":35571,"journal":{"name":"Advances in Food and Nutrition Research","volume":"105 ","pages":"301-342"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Food and Nutrition Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/bs.afnr.2022.12.003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Agricultural and Biological Sciences","Score":null,"Total":0}
引用次数: 0

Abstract

Clinical nutrition emulsions are important products that can be life-saving for many patients suffering from gastrointestinal tract disorders, swallowing impairment, cancer, liver diseases, and many other clinical conditions. The transfer of lipids to the human body can be either intravenously (Parenteral Nutrition, PN) or through the gastrointestinal tract (Enteral Nutrition, EN). PN emulsions are considered pharmaceuticals and thus regulated accordingly. On the other hand, EN emulsions are classified as Food for Specific Medical Purposes (FSMP) and do not follow pharmaceutical regulations. Regarding product design, PN emulsions must follow theoretical emulsion formulation and production aspects, but special requirements regarding droplet size distribution must be followed to comply with national pharmacopeia monographs. Furthermore, a full clinical program on clinical evidence to prove safety and efficacy must be provided for marketing approval. On the contrary, EN emulsions require limited clinical evidence to substantiate health or clinical benefits. A short introduction to clinical nutrition with a focus on lipid emulsions is presented in this chapter. Furthermore, a general overview of the composition and main ingredients of clinical nutrition lipid emulsions is reviewed. Main clinical aspects are also mentioned here, highlighting the difficulties of clinically proving the efficacy of these products. The manufacturing and control of clinical nutrition emulsions are also reviewed, focusing on PN products and the main regulatory requirements related to the safety of these intravenous emulsions. Finally, stability and physicochemical properties are reviewed, and examples of commercially available products are used to illustrate these properties linked to the stability of these products. Lipids in clinical nutrition is a moving field and we do hope this chapter may remain a valuable source to understand newly emerging research on this topic.

脂质乳剂在临床营养中的应用:肠内和肠外营养。
临床营养乳剂是重要的产品,可以挽救许多患有胃肠道疾病、吞咽障碍、癌症、肝脏疾病和许多其他临床疾病的患者的生命。脂质向人体的转移可以通过静脉(肠外营养,PN)或通过胃肠道(肠内营养,EN)。PN乳剂被认为是药品,因此受到相应的管制。另一方面,EN乳剂被归类为特定医疗用途食品(FSMP),不遵守制药法规。在产品设计方面,PN乳液必须遵循理论乳液配方和生产方面的要求,但在液滴尺寸分布方面必须遵循国家药典各论的特殊要求。此外,必须提供完整的临床证据来证明安全性和有效性,以获得市场批准。相反,EN乳剂需要有限的临床证据来证实健康或临床益处。一个简短的介绍,临床营养与重点脂质乳剂是在本章提出。对临床营养脂质乳的组成及主要成分进行了综述。这里也提到了主要的临床方面,强调了临床证明这些产品疗效的困难。对临床营养乳剂的生产和控制也进行了回顾,重点是PN产品和与这些静脉注射乳剂安全性相关的主要监管要求。最后,回顾了稳定性和物理化学性质,并以市售产品为例说明了这些性质与这些产品的稳定性有关。临床营养中的脂质是一个不断发展的领域,我们希望本章可以成为理解这一主题的新研究的有价值的来源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Advances in Food and Nutrition Research
Advances in Food and Nutrition Research Agricultural and Biological Sciences-Food Science
CiteScore
8.50
自引率
0.00%
发文量
50
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信